Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City, 61074 [2019-24543]

Download as PDF 61074 Federal Register / Vol. 84, No. 218 / Tuesday, November 12, 2019 / Notices projects and programs in the following technology areas: Multi-function Materials, Cyber, Big Data Analytics/ Artificial Intelligence/Machine Learning, Directed Energy Science & Engineering, Advanced Computing and Software Engineering, Autonomous and Unmanned Systems, Sensor Systems, Gun and Projectile Systems, Digital Engineering, Human Systems Integration, Quantum Technologies, Threat Engineering, Mission Engineering and Analysis, Integrated Warfare Systems, Virtualization, Asymmetric Warfare, Manufacturing, Lethality, Surface Offensive & Defensive Engagements, and Launcher Technology. Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2019–24483 Filed 11–8–19; 8:45 am] BILLING CODE 4410–11–P Controlled substance Drug code Levorphanol ................... Morphine ........................ Oripavine ....................... Thebaine ........................ Oxymorphone ................ Noroxymorphone ........... Tapentadol ..................... Fentanyl ......................... 9220 9300 9330 9333 9652 9668 9780 9801 Schedule II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for conversion and sale to finished dosage form manufacturers. In reference to drug codes 7360 (marihuana), and 7370 (tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic cannabidiol (CBD) and tetrahydrocannabinol (THC). No other activities for drug codes 7360 and 7370 are authorized for this registration. Dated: October 30, 2019. William T. McDermott, Assistant Administrator. DEPARTMENT OF JUSTICE [FR Doc. 2019–24545 Filed 11–8–19; 8:45 am] Drug Enforcement Administration BILLING CODE 4410–09–P [Docket No. DEA–541] DEPARTMENT OF JUSTICE Bulk Manufacturer of Controlled Substances Application: Rhodes Technologies ACTION: Drug Enforcement Administration Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 13, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on August 16, 2019, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: DATES: Controlled substance Marihuana ...................... Tetrahydrocannabinols .. Dihydromorphine ........... Methylphenidate ............ Codeine ......................... Dihydrocodeine .............. Oxycodone .................... Hydromorphone ............. Hydrocodone ................. VerDate Sep<11>2014 Drug code 7360 7370 9145 1724 9050 9120 9143 9150 9193 17:47 Nov 08, 2019 Schedule I I I II II II II II II Jkt 250001 Lisdexamfetamine .. Methylphenidate ..... ANPP (4-Anilino-Nphenethyl-4-piperidine). Phenylacetone ........ Cocaine .................. Codeine .................. Oxycodone ............. Hydromorphone ...... Hydrocodone .......... Morphine ................. Oripavine ................ Thebaine ................. Opium extracts ....... Opium fluid extract Opium tincture ........ Opium, powdered ... Oxymorphone ......... Noroxymorphone .... Fentanyl .................. Schedule 1205 1724 8333 II II II 8501 9041 9050 9143 9150 9193 9300 9330 9333 9610 9620 9630 9639 9652 9668 9801 II II II II II II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for conversion to other controlled substances and sale to its customers, for dosage form development, for clinical trials, and for use in stability qualification studies. Dated: October 30, 2019. William T. McDermott, Assistant Administrator. BILLING CODE 4410–09–P Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City ACTION: Drug code [FR Doc. 2019–24543 Filed 11–8–19; 8:45 am] [Docket No. DEA–539] Notice of application. Controlled substance DEPARTMENT OF JUSTICE Drug Enforcement Administration Notice of application. [Docket No. DEA–534] Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 13, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. DATES: In accordance with 21 CFR 1301.33(a), this is notice that on May 15, 2019, Cambrex Charles City, 1205 11th Street, Charles City, Iowa 50616–3466 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Controlled substance Drug code Gamma Hydroxybutyric Acid. Amphetamine ......... PO 00000 Frm 00070 Fmt 4703 Schedule 2010 I 1100 II Sfmt 4703 Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Lab ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 13, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on July 24, 2019 Cambridge Isotope Lab, 50 Frontage Road, Andover, Massachusetts 01810–5413 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: DATES: E:\FR\FM\12NON1.SGM 12NON1

Agencies

[Federal Register Volume 84, Number 218 (Tuesday, November 12, 2019)]
[Notices]
[Page 61074]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24543]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-539]


Bulk Manufacturer of Controlled Substances Application: Cambrex 
Charles City

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before January 13, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on May 15, 2019, Cambrex Charles City, 1205 11th Street, 
Charles City, Iowa 50616-3466 applied to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid............        2010  I
Amphetamine..........................        1100  II
Lisdexamfetamine.....................        1205  II
Methylphenidate......................        1724  II
ANPP (4-Anilino-N-phenethyl-4-               8333  II
 piperidine).
Phenylacetone........................        8501  II
Cocaine..............................        9041  II
Codeine..............................        9050  II
Oxycodone............................        9143  II
Hydromorphone........................        9150  II
Hydrocodone..........................        9193  II
Morphine.............................        9300  II
Oripavine............................        9330  II
Thebaine.............................        9333  II
Opium extracts.......................        9610  II
Opium fluid extract..................        9620  II
Opium tincture.......................        9630  II
Opium, powdered......................        9639  II
Oxymorphone..........................        9652  II
Noroxymorphone.......................        9668  II
Fentanyl.............................        9801  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for conversion to other controlled substances and sale to its 
customers, for dosage form development, for clinical trials, and for 
use in stability qualification studies.

    Dated: October 30, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-24543 Filed 11-8-19; 8:45 am]
 BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.